Cytek Biosciences, Inc.
CTKB
$3.77
-$0.05-1.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.03% | 0.20% | 2.64% | 2.93% | -8.89% |
| Total Receivables | 15.06% | 17.66% | -11.16% | -10.24% | -2.63% |
| Inventory | -6.08% | -6.51% | -8.76% | -10.20% | -9.29% |
| Prepaid Expenses | 47.39% | 12.32% | -39.19% | 15.53% | 9.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -4.14% | 6.01% | 6.33% | 3.36% | 49.86% |
| Total Current Assets | 1.60% | 1.59% | -1.17% | -0.87% | -7.16% |
|
|
|||||
| Total Current Assets | 1.60% | 1.59% | -1.17% | -0.87% | -7.16% |
| Net Property, Plant & Equipment | -1.75% | 4.34% | -2.67% | -3.63% | 0.48% |
| Long-term Investments | 2.97% | 0.00% | 0.00% | 0.00% | -1.66% |
| Goodwill | 2.97% | 0.00% | 0.00% | 0.00% | -1.66% |
| Total Other Intangibles | -1.78% | -4.33% | -3.74% | -3.60% | -4.97% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.05% | -1.35% | -1.69% | 3.89% | 32.06% |
| Total Assets | 1.68% | 1.55% | -1.70% | -0.48% | -4.81% |
|
|
|||||
| Total Accounts Payable | 2.60% | 68.88% | -14.34% | 22.86% | -35.64% |
| Total Accrued Expenses | 7.80% | 39.94% | -14.81% | -11.14% | -4.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -22.98% | 27.53% | 53.76% | -6.35% | -12.20% |
| Total Finance Division Other Current Liabilities | 0.84% | 4.22% | -0.87% | -1.43% | 1.90% |
| Total Other Current Liabilities | 0.84% | 4.22% | -0.87% | -1.43% | 1.90% |
| Total Current Liabilities | 7.75% | 19.89% | -5.74% | -1.17% | -4.20% |
|
|
|||||
| Total Current Liabilities | 7.75% | 19.89% | -5.74% | -1.17% | -4.20% |
| Long-Term Debt | -15.05% | -7.07% | -9.95% | -10.38% | -5.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.63% | -4.40% | -6.71% | -8.25% | -6.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.06% | 3.64% | -2.77% | -0.96% | 2.11% |
| Total Liabilities | -1.89% | 11.80% | -4.88% | -1.91% | -2.42% |
|
|
|||||
| Common Stock & APIC | 0.17% | -1.13% | 1.30% | 1.42% | -6.26% |
| Retained Earnings | 21.50% | 2.06% | -29.52% | -21.14% | 15.87% |
| Treasury Stock & Other | -84.16% | 151.79% | 87.45% | -21.88% | 19.25% |
| Total Common Equity | 2.67% | -0.94% | -0.89% | -0.11% | -5.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.67% | -0.94% | -0.89% | -0.11% | -5.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.67% | -0.94% | -0.89% | -0.11% | -5.41% |
|
|
|||||